SPLICE VARIANTS OF HUMAN G-PROTEIN COUPLED RECEPTOR HGPRBMY29 (HGPRMBY29SV2)
    22.
    发明申请
    SPLICE VARIANTS OF HUMAN G-PROTEIN COUPLED RECEPTOR HGPRBMY29 (HGPRMBY29SV2) 有权
    人G蛋白偶联受体HGPRBMY29(HGPRBMY29SV2)的差异变体

    公开(公告)号:US20120010385A1

    公开(公告)日:2012-01-12

    申请号:US11891240

    申请日:2007-08-09

    IPC分类号: C07K14/00 C07H21/04

    摘要: The present invention provides novel polynucleotides encoding HGPRBMY28 and HGPRBMY29 polypeptides, fragments and homologues thereof. The present invention also provides polynucleotides encoding splice variants of HGPRBMY29 polypeptides, HGPRBMY29v1 and HGPRBMY29v2. Also provided are vectors, host cells, antibodies, and recombinant and synthetic methods for producing said polypeptides. Also provided are vectors, host cells, antibodies, and recombinant and synthetic methods for producing said polypeptides. The invention further relates to diagnostic and therapeutic methods for applying these novel HGPRBMY28, HGPRBMY29, HGPRBMY29v1, and HGPRBMY29v2 polypeptides to the diagnosis, treatment, and/or prevention of various diseases and/or disorders related to these polypeptides. The invention further relates to screening methods for identifying agonists and antagonists of the polynucleotides and polypeptides of the present invention.

    摘要翻译: 本发明提供编码HGPRBMY28和HGPRBMY29多肽的新型多核苷酸,其片段及其同源物。 本发明还提供编码HGPRBMY29多肽,HGPRBMY29v1和HGPRBMY29v2的剪接变体的多核苷酸。 还提供了载体,宿主细胞,抗体以及用于产生所述多肽的重组和合成方法。 还提供了载体,宿主细胞,抗体以及用于产生所述多肽的重组和合成方法。 本发明还涉及将这些新型HGPRBMY28,HGPRBMY29,HGPRBMY29v1和HGPRBMY29v2多肽应用于诊断,治疗和/或预防与这些多肽相关的各种疾病和/或病症的诊断和治疗方法。 本发明还涉及用于鉴定本发明的多核苷酸和多肽的激动剂和拮抗剂的筛选方法。

    Human G-protein coupled receptor, HGPRBMY29sv1 polypeptides
    23.
    发明授权
    Human G-protein coupled receptor, HGPRBMY29sv1 polypeptides 有权
    人G蛋白偶联受体,HGPRBMY29sv1多肽

    公开(公告)号:US07345148B2

    公开(公告)日:2008-03-18

    申请号:US11070456

    申请日:2005-03-02

    摘要: The present invention provides novel polynucleotides encoding HGPRBMY28 and HGPRBMY29 polypeptides, fragments and homologues thereof. The present invention also provides polynucleotides encoding splice variants of HGPRBMY29 polypeptides, HGPRBMY29v1 and HGPRBMY29v2. Also provided are vectors, host cells, antibodies, and recombinant and synthetic methods for producing said polypeptides. Also provided are vectors, host cells, antibodies, and recombinant and synthetic methods for producing said polypeptides. The invention further relates to diagnostic and therapeutic methods for applying these novel HGPRBMY28, HGPRBMY29, HGPRBMY29v1, and HGPRBMY29v2 polypeptides to the diagnosis, treatment, and/or prevention of various diseases and/or disorders related to these polypeptides. The invention further relates to screening methods for identifying agonists and antagonists of the polynucleotides and polypeptides of the present invention.

    摘要翻译: 本发明提供编码HGPRBMY28和HGPRBMY29多肽的新型多核苷酸,其片段及其同源物。 本发明还提供编码HGPRBMY29多肽,HGPRBMY29v1和HGPRBMY29v2的剪接变体的多核苷酸。 还提供了载体,宿主细胞,抗体以及用于产生所述多肽的重组和合成方法。 还提供了载体,宿主细胞,抗体以及用于产生所述多肽的重组和合成方法。 本发明还涉及将这些新型HGPRBMY28,HGPRBMY29,HGPRBMY29v1和HGPRBMY29v2多肽应用于诊断,治疗和/或预防与这些多肽相关的各种疾病和/或病症的诊断和治疗方法。 本发明还涉及用于鉴定本发明的多核苷酸和多肽的激动剂和拮抗剂的筛选方法。

    Polynucleotides encoding a novel human G-protein coupled receptor splice variant, HGPRBMY29SV2
    24.
    发明授权
    Polynucleotides encoding a novel human G-protein coupled receptor splice variant, HGPRBMY29SV2 有权
    编码新型人G蛋白偶联受体剪接变体的多核苷酸HGPRBMY29SV2

    公开(公告)号:US07276354B2

    公开(公告)日:2007-10-02

    申请号:US11071761

    申请日:2005-03-03

    摘要: The present invention provides novel polynucleotides encoding HGPRBMY28 and HGPRBMY29 polypeptides, fragments and homologues thereof. The present invention also provides polynucleotides encoding splice variants of HGPRBMY29 polypeptides, HGPRBMY29v1 and HGPRBMY29v2. Also provided are vectors, host cells, antibodies, and recombinant and synthetic methods for producing these polypeptides. Also provided are vectors, host cells, antibodies, and recombinant and synthetic methods for producing these polypeptides. The invention further relates to diagnostic and therapeutic methods for applying these novel HGPRBMY28, HGPRBMY29, HGPRBMY29v1, and HGPRBMY29v2 polypeptides to the diagnosis, treatment, and/or prevention of various diseases and/or disorders related to these polypeptides. The invention further relates to screening methods for identifying agonists and antagonists of the polynucleotides and polypeptides of the present invention.

    摘要翻译: 本发明提供编码HGPRBMY28和HGPRBMY29多肽的新型多核苷酸,其片段及其同源物。 本发明还提供编码HGPRBMY29多肽,HGPRBMY29v1和HGPRBMY29v2的剪接变体的多核苷酸。 还提供了载体,宿主细胞,抗体以及用于产生这些多肽的重组和合成方法。 还提供了载体,宿主细胞,抗体以及用于产生这些多肽的重组和合成方法。 本发明还涉及将这些新型HGPRBMY28,HGPRBMY29,HGPRBMY29v1和HGPRBMY29v2多肽应用于诊断,治疗和/或预防与这些多肽相关的各种疾病和/或病症的诊断和治疗方法。 本发明还涉及用于鉴定本发明的多核苷酸和多肽的激动剂和拮抗剂的筛选方法。

    Polynucleotides encoding a novel human G-protein coupled receptor splice variant HGPRBMY29sv1
    25.
    发明授权
    Polynucleotides encoding a novel human G-protein coupled receptor splice variant HGPRBMY29sv1 有权
    编码新型人G蛋白偶联受体剪接变体HGPRBMY29sv1的多核苷酸

    公开(公告)号:US07049096B2

    公开(公告)日:2006-05-23

    申请号:US10120604

    申请日:2002-04-11

    摘要: The present invention provides novel polynucleotides encoding HGPRBMY28 and HGPRBMY29 polypeptides, fragments and homologues thereof. The present invention also provides polynucleotides encoding splice variants of HGPRBMY29 polypeptides, HGPRBMY29v1 and HGPRBMY29v2. Also provided are vectors, host cells, antibodies, and recombinant and synthetic methods for producing said polypeptides. Also provided are vectors, host cells, antibodies, and recombinant and synthetic methods for producing said polypeptides. The invention further relates to diagnostic and therapeutic methods for applying these novel HGPRBMY28, HGPRBMY29, HGPRBMY29v1, and HGPRBMY29v2 polypeptides to the diagnosis, treatment, and/or prevention of various diseases and/or disorders related to these polypeptides. The invention further relates to screening methods for identifying agonists and antagonists of the polynucleotides and polypeptides of the present invention.

    摘要翻译: 本发明提供编码HGPRBMY28和HGPRBMY29多肽的新型多核苷酸,其片段及其同源物。 本发明还提供编码HGPRBMY29多肽,HGPRBMY29v1和HGPRBMY29v2的剪接变体的多核苷酸。 还提供了载体,宿主细胞,抗体以及用于产生所述多肽的重组和合成方法。 还提供了载体,宿主细胞,抗体以及用于产生所述多肽的重组和合成方法。 本发明还涉及将这些新型HGPRBMY28,HGPRBMY29,HGPRBMY29v1和HGPRBMY29v2多肽应用于诊断,治疗和/或预防与这些多肽相关的各种疾病和/或病症的诊断和治疗方法。 本发明还涉及用于鉴定本发明的多核苷酸和多肽的激动剂和拮抗剂的筛选方法。

    Polynucleotides encoding a novel metalloprotease, MP-1
    26.
    发明授权
    Polynucleotides encoding a novel metalloprotease, MP-1 有权
    编码新型金属蛋白酶MP-1的多核苷酸

    公开(公告)号:US06642041B2

    公开(公告)日:2003-11-04

    申请号:US10067443

    申请日:2002-02-05

    IPC分类号: C12N948

    CPC分类号: C12N9/6489 C07K2299/00

    摘要: The present invention provides novel polynucleotides encoding MP-1 polypeptides, fragments and homologues thereof. Also provided are vectors, host cells, antibodies, and recombinant and synthetic methods for producing said polypeptides. The invention further relates to diagnostic and therapeutic methods for applying these novel MP-1 polypeptides to the diagnosis, treatment, and/or prevention of various diseases and/or disorders related to these polypeptides. The invention further relates to screening methods for identifying agonists and antagonists of the polynucleotides and polypeptides of the present invention.

    摘要翻译: 本发明提供了编码MP-1多肽,其片段和同系物的新型多核苷酸。 还提供了载体,宿主细胞,抗体以及用于产生所述多肽的重组和合成方法。 本发明还涉及将这些新型MP-1多肽应用于诊断,治疗和/或预防与这些多肽相关的各种疾病和/或病症的诊断和治疗方法。 本发明还涉及用于鉴定本发明的多核苷酸和多肽的激动剂和拮抗剂的筛选方法。

    POLYNUCLEOTIDES ENCODING NOVEL PCSK9 VARIANTS
    28.
    发明申请
    POLYNUCLEOTIDES ENCODING NOVEL PCSK9 VARIANTS 有权
    多核苷酸编码新的PCSK9变体

    公开(公告)号:US20120129237A1

    公开(公告)日:2012-05-24

    申请号:US13336371

    申请日:2011-12-23

    IPC分类号: C12N9/64 C12N9/96

    摘要: The present invention provides novel polynucleotides encoding PCSK9b and PCSK9c polypeptides, fragments and homologues thereof. Also provided are vectors, host cells, antibodies, and recombinant and synthetic methods for producing said polypeptides. The invention further relates to diagnostic and therapeutic methods for applying these novel PCSK9b and PCSK9c polypeptides to the diagnosis, treatment, and/or prevention of various diseases and/or disorders related to these polypeptides. The invention further relates to screening methods for identifying agonists and antagonists of the polynucleotides and polypeptides of the present invention.

    摘要翻译: 本发明提供了编码PCSK9b和PCSK9c多肽的新型多核苷酸,其片段和同源物。 还提供了载体,宿主细胞,抗体以及用于产生所述多肽的重组和合成方法。 本发明还涉及将这些新型PCSK9b和PCSK9c多肽应用于诊断,治疗和/或预防与这些多肽相关的各种疾病和/或病症的诊断和治疗方法。 本发明还涉及用于鉴定本发明的多核苷酸和多肽的激动剂和拮抗剂的筛选方法。

    Polynucleotides encoding novel PCSK9 variants
    29.
    发明申请
    Polynucleotides encoding novel PCSK9 variants 有权
    编码新型PCSK9变体的多核苷酸

    公开(公告)号:US20100003736A1

    公开(公告)日:2010-01-07

    申请号:US12456798

    申请日:2009-06-23

    IPC分类号: C12N9/50 C12N9/96

    摘要: The present invention provides novel polynucleotides encoding PCSK9b and PCSK9c polypeptides, fragments and homologues thereof. Also provided are vectors, host cells, antibodies, and recombinant and synthetic methods for producing said polypeptides. The invention further relates to diagnostic and therapeutic methods for applying these novel PCSK9b and PCSK9c polypeptides to the diagnosis, treatment, and/or prevention of various diseases and/or disorders related to these polypeptides. The invention further relates to screening methods for identifying agonists and antagonists of the polynucleotides and polypeptides of the present invention.

    摘要翻译: 本发明提供了编码PCSK9b和PCSK9c多肽的新型多核苷酸,其片段和同源物。 还提供了载体,宿主细胞,抗体以及用于产生所述多肽的重组和合成方法。 本发明还涉及将这些新型PCSK9b和PCSK9c多肽应用于诊断,治疗和/或预防与这些多肽相关的各种疾病和/或病症的诊断和治疗方法。 本发明还涉及用于鉴定本发明的多核苷酸和多肽的激动剂和拮抗剂的筛选方法。